Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has released a report concerning the status of the net proceeds from their 2015 share placement. The company confirmed the accuracy and fairness of the announcement and detailed the use and deposit of the net proceeds, which after expenses, amounts to approximately RMB814,340,000.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
